by Roman Langston | May 9, 2019 | Blog, Popular
One of the leading causes of disability in the U.S. is major depressive disorder (MDD), affecting more than 16.1 million adults each year. Another perhaps more shocking statistic is that about 80% of those people never seek treatment, for various reasons. However, one...
by Roman Langston | Apr 3, 2019 | Blog, Popular
The recent FDA approval of the use of esketamine for treatment-resistant depression means many Americans suffering will soon find relief. The drug, Spravato, was approved for patients who have failed to respond at all to at least two other antidepressant medications....
